Free Trial

Dr. Martens plc (LON:DOCS) Insider Giles Wilson Buys 194 Shares

Dr. Martens logo with Consumer Cyclical background

Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson purchased 194 shares of the stock in a transaction dated Friday, July 11th. The stock was acquired at an average price of GBX 77 ($1.03) per share, for a total transaction of £149.38 ($200.46).

Giles Wilson also recently made the following trade(s):

  • On Wednesday, June 11th, Giles Wilson bought 189 shares of Dr. Martens stock. The shares were purchased at an average price of GBX 79 ($1.06) per share, for a total transaction of £149.31 ($200.36).

Dr. Martens Stock Performance

LON DOCS traded up GBX 0.30 ($0.00) on Thursday, hitting GBX 78.80 ($1.06). The stock had a trading volume of 826,464 shares, compared to its average volume of 2,127,686. Dr. Martens plc has a one year low of GBX 43.02 ($0.58) and a one year high of GBX 83.30 ($1.12). The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27. The stock has a market cap of £764.96 million, a price-to-earnings ratio of 11.17, a P/E/G ratio of 6.40 and a beta of 0.11. The company's 50-day moving average is GBX 69 and its two-hundred day moving average is GBX 64.12.

Dr. Martens (LON:DOCS - Get Free Report) last posted its earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, analysts expect that Dr. Martens plc will post 2.5809394 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on DOCS. Royal Bank Of Canada cut their target price on shares of Dr. Martens from GBX 7,000 ($93.93) to GBX 6,000 ($80.52) and set a "sector perform" rating on the stock in a research note on Monday, May 19th. Deutsche Bank Aktiengesellschaft reiterated a "hold" rating on shares of Dr. Martens in a report on Friday, July 11th.

Get Our Latest Report on Dr. Martens

About Dr. Martens

(Get Free Report)

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

Featured Stories

Insider Buying and Selling by Quarter for Dr. Martens (LON:DOCS)

Should You Invest $1,000 in Dr. Martens Right Now?

Before you consider Dr. Martens, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.

While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines